FolioLanternBeta
MIRMMirum Pharmaceuticals, Inc.

Peter Radovich

President and COO at Mirum Pharmaceuticals, Inc., as of Jun 8, 2026Sold $2.3M of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
57K
shares held after the latest filing, Mirum Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
25K
shares sold, past 12 months
4
days with sales
$1.5M
largest single day, Mar 16, 2026
1
company filed for

Share of stake sold at Mirum Pharmaceuticals, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $525K to cover taxesJanFeb 2026: $272K to cover taxesFebMar 2026: $1.5M to cover taxes$1.5MMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Mirum Pharmaceuticals, Inc. (MIRM)President and COOApr 30, 2020Jun 8, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.